Rifaximin 550 MG Oral Tablet [XIFAXAN]

DRUG2 trials

Sponsors

Wake Forest University Health Sciences, University of North Carolina, Chapel Hill

Conditions

Abdominal PainCystic FibrosisPouchitisSmall Bowel Disease

Phase 2

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

WithdrawnNCT05408910

Wake Forest University Health SciencesAbdominal Pain, Cystic Fibrosis, Small Bowel Disease

Start: 2025-07-31End: 2025-09-30Updated: 2025-06-27

Phase 4

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

RecruitingNCT06312683

University of North Carolina, Chapel HillPouchitis

Start: 2024-07-01End: 2027-07-01Target: 16Updated: 2026-08-03